Development Level

Tbio 3 | 10,625
Tchem 2 | 1,890

IMPC Term

abnormal QRS complex 1 | 25

Disease

Alzheimer's disease 3 | 644
Arthritis 3 | 248
Asthma 3 | 349
Autistic Disorder 3 | 320
Cancer 3 | 2,346
Hepatitis C 3 | 90
Inflammatory bowel disease 3 | 142
Irritable bowel syndrome 3 | 59
psoriasis 3 | 6,685
Allergic hypersensitivity disease 2 | 123
Chronic obstructive pulmonary disease 2 | 146
Dermatitis 2 | 107
Diarrhea 2 | 155
Hyperalgesia 2 | 71
Hypertension 2 | 287
Migraine 2 | 79
Neuropathy 2 | 210
Obesity 2 | 616
Prostatic Neoplasms 2 | 471
Rhinitis 2 | 46
astrocytic glioma 2 | 2,241
colon cancer 2 | 1,475
diabetes mellitus 2 | 1,663
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
lung carcinoma 2 | 2,844
medulloblastoma, large-cell 2 | 6,234
osteosarcoma 2 | 7,933
periodontitis 2 | 269
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087
Acute Lung Injury 1 | 18
Acute kidney injury 1 | 65
Adult T-Cell Lymphoma/Leukemia 1 | 30
Alcohol dependence 1 | 107
Anxiety Disorders 1 | 37
Appendicitis 1 | 18
Arthritis, Experimental 1 | 39
Aspergillosis 1 | 23
Bronchial Hyperreactivity 1 | 13
Candidiasis 1 | 48
Chlamydia 1 | 18
Cholera 1 | 33
Common cold 1 | 63
Complex regional pain syndrome 1 | 12
Constipation 1 | 43
Dengue disease 1 | 19
Diabetes Mellitus, Insulin-Dependent 1 | 76
Eating disorder 1 | 24
Echinococcosis 1 | 28
Edema 1 | 38
Ehrlichiosis 1 | 9
Encephalitis 1 | 54
Epicondylitis 1 | 19
Fibromyalgia 1 | 22
Filariasis 1 | 21
Gastritis 1 | 44
Glomerulonephritis 1 | 36
HIV Infections 1 | 100
Hepatolenticular Degeneration 1 | 24
Hirschsprung's disease 1 | 42
Human immunodeficiency virus infectious disease 1 | 92
Hyperactive behavior 1 | 31
Hyperglycemia 1 | 120
Hypokalemia 1 | 40
Hypotension 1 | 53
Impotence 1 | 45
Inflammatory disease of mucous membrane 1 | 8
Keratoconjunctivitis sicca 1 | 19
Leishmaniasis, Visceral 1 | 13
Leprosy 1 | 77
Leukopenia 1 | 42
Liver Cirrhosis, Experimental 1 | 108
Liver disease 1 | 219
Lung Neoplasms 1 | 171
Lupus Erythematosus, Systemic 1 | 73
Lyme disease 1 | 23
Mammary Neoplasms, Experimental 1 | 150
Mastitis 1 | 48
Meningitis 1 | 46
Myocardial Infarction 1 | 126
Narcolepsy 1 | 58
Neoplasm Metastasis 1 | 138
Pain 1 | 70
Pancreatitis 1 | 97
Primary immunodeficiency disease 1 | 52
Prostatitis 1 | 15
Q fever 1 | 11
Respiratory failure 1 | 30
Schistosomiasis 1 | 38
Sepsis 1 | 21
Tetanus 1 | 66
Thrombocytopenia 1 | 105
Toxic shock syndrome 1 | 28
Toxoplasmosis 1 | 16
Type 1 diabetes mellitus 1 | 101
Uveitis 1 | 103
Weight decreased 1 | 18
chronic kidney disease 1 | 90
interstitial lung disease 1 | 291
sarcoidosis 1 | 358

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 5 | 11,971

Grant Application

2R01EY002986-26 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
VIP peptides VIP Tbio Non-IDG -3.54298 4022.9 276
Secretogranin-2 SCG2 Tbio Non-IDG -2.34568 273.4 160
Marginal zone B- and B1-cell-specific protein MZB1 Tbio Non-IDG -0.97428 13.9 63
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Interleukin-10 IL10 Tchem Non-IDG -4.03858 11514.6 1151